1007 pf 655 preclinical indications technology technology publications partners partners scientific collaborations intellectual property intellectual property ip announcements news news events contact contact careers loading ... welcome to quark an rnai based late stage clinical company check our phase iii pivotal studies vertically integrated from gene discovery to novel therapeutics learn more strong pipeline of clinical and preclinical product candidates check pipeline freedom to operate in the nucleic acid intellectual property space read more on our intellectual property quark home pageeyal2015 09 01t12 09 27 00 00 our leading productsqpi 1002 phase iii qpi 1007 phase iii pf 655 phase ii check pipelinelatest newseyal2016 10 16t08 32 15 00 00quark pharmaceuticals launches eyeactnow.com to promote naion study steps up recruitment for phase ii iii research on stroke of the eye october 14th 2016eyal2016 09 19t15 26 36 00 00quark pharmaceuticals chief scientist provides an overview of the company s clinical and nonclinical pipelinesseptember 19th 2016quark pharmaceuticals inc. is a clinical stage pharmaceutical company that is a leader in the discovery and development of novel rnai based therapeutics . eventseyal2015 09 03t06 42 58 00 00quark will present at eurotides 2015 maritim proarte hotel berlin germany 16 18 nov 2015eyal2015 08 26t12 27 53 00 00quark will present at 2015 american transplant congress may 5 2015eyal2015 08 26t12 28 40 00 00quark will present at tides 2015 at the town and country hotel in san diego ca may 3 6 2015technologywe have a fully integrated research and development team with a proven track record of translating our innovations in rnai therapeutics from the bench to the clinic . we have full capabilities in the areas of cell and molecular biology protein biochemistry monoclonal antibody technology bioinformatics animal pharmacology histopathology including immunohistochemistry and in situ hybridization and drug delivery . our development teams to date have progressed three drug candidates through four inds into clinical studies in five different disease indications . about quark quark pharmaceuticals inc. is a clinical stage pharmaceutical company that is a leader in the discovery and development of novel rnai based therapeutics . contact info headquarters quark pharmaceuticals inc. usa 6501 dumbarton circle fremont ca 94555 phone 510.402.4020 fax 510.402.4021 email qbi quarkpharma.com research qbi enterprises ltd. weizmann science park p.o.b. 4071 ness ziona 70400 israel . phone 972 8 9305 111 fax 972 8 9406 476 e mail qbi quarkpharma.com human resource for us operations hr us quarkpharma.com for israel operations hr il quarkpharma.com business development juliana friedman email jfriedman quarkpharma.com categories events news open positions in fremont open positions in israel patents terms of useterms of use copyright info privacy policy copyright 2015 quark all rights reserved